关于青少年无形性关节炎的生物治疗的最新情况:五年叙述审查
Adele Civino1, Federico Diomeda1, Marco Burrone2,3
1Division of Pediatric Rheumatology and Immunology, Vito Fazzi Hospital, Lecce, Italy.
Biologics : targets & therapy
|July 28, 2025
概括
生物时代通过新药和早期干预改变了青少年异常性关节炎 (JIA) 护理. 目前正在进行的研究旨在改善治疗个性化,并解决JIA管理中的剩余挑战.
科学领域:
- 儿科风湿病学 儿科风湿病学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 青少年异常性关节炎 (JIA) 的生物时代始于2000年,引入了像etanercept这样的新疗法.
- 进展包括新的生物修饰性抗风湿药物 (bDMARDs) 和朝着早期,积极的干预措施的迈进.
- 治疗指南和现实世界的数据改善了对bDMARDs在JIA中的有效性和安全性的理解.
研究的目的:
- 审查过去五年来对JIA生物治疗的最新进展.
- 讨论JIA治疗当前的差距,包括药物停用和非响应患者的替代方案.
- 探索个性化JIA治疗的未来研究方向.
主要方法:
- 系统审查过去五年出版的文献.
- 对临床试验数据和对bDMARDs在JIA中的现实世界的证据的分析.
- 评估目前的JIA管理策略和指导方针.
主要成果:
- 通过bDMARDs和早期干预策略,在JIA管理方面取得了重大进展.
- 识别创新的方法,如逐步治疗和治疗到目标.
- 越来越多的证据证明了各种bDMARDs在JIA亚型中的有效性和安全性.
结论:
- 生物疗法已经彻底改变了JIA的管理,但仍然存在未得到满足的需求.
- 需要进一步研究药物停药的标准以及对有不充分反应的患者的标准.
- 以预测生物标志物为指导的个性化治疗策略对于未来的JIA护理至关重要.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
235
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
235
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271
Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
Inflammatory Bowel Disease II: Crohn's Disease
387
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
387
Autoimmune Disorders
677
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
Concept and Mechanism of Autoimmune Diseases
The immune...
677


